相同又不同:CZT与NaI探测器扫描仪上的多巴胺转运体SPECT
本研究在CZT相机上建立[123I]FP-CIT SPECT半定量正常数据库(NDB),并比较既有NaI衍生NDB与新CZT NDB在73例临床不确定帕金森综合征受试者中的诊断表现。结果显示使用专用CZT NDB时半定量与视觉评级的 discordant 评级更少(48例中3例 vs 8例),且CZT与NaI数据间结合比与z分数存在显著差异。结论推荐在CZT相机[123I]FP-CIT SPECT中使用专用CZT衍生NDB。
要点
- CZT相机[123I]FP-CIT SPECT使用专用CZT NDB较GE NDB与视觉评级不一致更少(48例中3例 vs 8例)
- GE NDB在CZT相机上壳核z分数中位绝对差为1.68,提示最佳截断值可能为-0.5而非-2.0
- CZT与NaI数据比较,平均结合比与z分数在CZT显著更低
核心结论
- 推荐在CZT相机[123I]FP-CIT SPECT中使用专用CZT衍生NDB,因其提高半定量与视觉评估之间的一致性。
研究设计与样本
- 样本为73例临床不确定帕金森综合征受试者,前瞻性按标准指南在CZT相机上行[123I]FP-CIT SPECT,采集与重建方案相同(DaTQUANT)。
- 两名经验丰富读者视觉评估并将受试者二分为「非神经退行性帕金森综合征」与「神经退行性帕金森综合征」。
- 从「非神经退行性帕金森综合征」亚组随机选取25例建立CZT NDB,其余48例为「测试组」。
- 使用DaTQUANT测定特异性结合比(SBR),测试组壳核SBR值分别用CZT NDB与厂家提供的NaI基NDB(GE NDB)转换为z分数,以预设固定截断值-2二分类。
- 对全部73例中32例子集进行两种探测器系统的随机头对头半定量比较。
主要发现
- 以视觉评级为参考,基于专用CZT NDB的半定量在CZT扫描中较GE NDB产生更少不一致评级(48例中3例 vs 8例)。
- 此差异可归因于GE NDB在CZT相机上壳核z分数持续更高(中位绝对差1.68),提示GE NDB最佳截断值可能为-0.5而非-2.0。
- CZT数据较NaI数据平均结合比与z分数显著更低。
关键数值与推荐
- 预设固定截断值-2用于z分数二分类以区分神经退行性与非神经退行性帕金森综合征。
- GE NDB在CZT相机上壳核z分数中位绝对差为1.68,提示最佳截断值可能为-0.5而非-2.0。
临床怎么用
- 作者推荐在CZT相机[123I]FP-CIT SPECT中使用专用CZT衍生NDB以改善半定量与视觉评估的一致性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aims of this study were to establish a normal database (NDB) for semiquantification of dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with [123I]FP-CIT on a cadmium zinc telluride (CZT) camera, test the preexisting NaI-derived NDB for use in CZT scans, and compare the diagnostic findings in subjects imaged with a CZT scanner with either the preexisting NaI-based NDB or our newly defined CZT NDB. METHODS: The sample comprised 73 subjects with clinically uncertain parkinsonian syndrome (PS) who prospectively underwent [123I]FP-CIT SPECT on a CZT camera according to standard guidelines with identical acquisition and reconstruction protocols (DaTQUANT). Two experienced readers visually assessed the images and binarized the subjects into "non-neurodegenerative PS" and "neurodegenerative PS". Twenty-five subjects from the "non-neurodegenerative PS" subgroup were randomly selected to establish a CZT NDB. The remaining 48 subjects were defined as "test group". DaTQUANT was used to determine the specific binding ratio (SBR). For the test group, SBR values were transformed to z-scores for the putamen utilizing both the CZT NDB and the manufacturer-provided NaI-based NDB (GE NDB). A predefined fixed cut-off of -2 was used for dichotomization of z-scores to classify neurodegenerative and non-neurodegenerative PS. Performance of semiquantification using the two NDB to identify subjects with neurodegenerative PS was assessed in comparison with the visual rating. Furthermore, a randomized head-to-head comparison of both detector systems was performed semiquantitatively in a subset of 32 out of all 73 subjects. RESULTS: Compared to the visual rating as reference, semiquantification based on the dedicated CZT NDB led to fewer discordant ratings than the GE NDB in CZT scans (3 vs. 8 out of 48 subjects). This can be attributed to the putaminal z-scores being consistently higher with the GE NDB on a CZT camera (median absolute difference of 1.68), suggesting an optimal cut-off of -0.5 for the GE NDB instead of -2.0. Average binding ratios and z-scores were significantly lower in CZT compared to NaI data. CONCLUSIONS: Use of a dedicated, CZT-derived NDB is recommended in [123I]FP-CIT SPECT with a CZT camera since it improves agreement between semiquantification and visual assessment.
引用
- Thiele F, Schau F, Rogasch JMM, et al. Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors. EJNMMI Res. 2023. PMID: 36949290. doi:10.1186/s13550-023-00973-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。